According to Business Objects, IBM’s Clinical Genomics solution is now enhanced with business intelligence capabilities from Business Objects. The solution is said to enable healthcare and life sciences companies to quickly synthesize and visualize genomic and pharmacogenomic information used in critical tasks, such as the development of new customized drug therapies and the improvement of patient diagnosis and treatment.
Business Objects proposes that additional uses for the solution could include helping organizations identify a list of potential candidates that fit a profile for a research study, as well as predicting at risk patients based on their similarity to a patient cluster – ultimately improving the effectiveness of diagnosis and treatment.
Robb Eklund, VP of marketing at Business Objects, said, Most genomics data is buried in complex data mining models that very few people can access and understand. The IBM CG solution can bring this data together, from wherever it may reside, with Business Objects providing rich visualization and simplified analysis for doctors and researchers who need it. Although these doctors need a degree in medicine, they won’t need a degree in mathematics to use and understand the data.
This article is from the CBROnline archive: some formatting and images may not be present.
CBR Online legacy content.